| RS2080119161 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080120731 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2080121850 |
MED13
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2080161530 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2080162888 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080164185 |
LSS
|
Health Risk |
Pathogenic |
Alopecia-intellectual disability syndrome 4, Alopecia-intellectual disability syndrome 4 |
| RS2080164484 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2080167483 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080170537 |
ATM
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Hereditary cancer-predisposing syndrome |
| RS2080171293 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080176523 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080178937 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080180530 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2080187424 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 7 |
| RS2080188103 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080189052 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2080191127 |
KCNQ2
|
Health Risk |
Pathogenic/Likely pathogenic |
Seizures, benign familial neonatal |
| RS2080191165 |
STAT5B
|
Health Risk |
Pathogenic |
Growth hormone insensitivity with immune dysregulation 1, autosomal recessive |
| RS2080191422 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2080210194 |
KCNQ2
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080211640 |
KCNQ2
|
Health Risk |
Pathogenic |
— |
| RS2080213813 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080229346 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080230745 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2080231132 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2080231811 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080233713 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS2080238010 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2080239750 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080239833 |
KCNQ2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2080240053 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080245178 |
UBE3A
|
Health Risk |
Pathogenic |
Angelman syndrome, Angelman syndrome |
| RS2080245264 |
KCNQ2
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2080267597 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080267793 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080268991 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080274080 |
SPTBN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2080278571 |
SPTBN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2080280611 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080280639 |
ARID1A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2080284670 |
LSS
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2080284671 |
ARID1A
|
Health Risk |
Likely pathogenic |
ARID1A-related disorder, ARID1A-related disorder |
| RS2080290215 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080291800 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2080292910 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080294213 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080303837 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080304396 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2080305309 |
UBE3A
|
Health Risk |
Pathogenic |
— |
| RS2080305905 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2080306272 |
DOCK6
|
Health Risk |
Likely pathogenic |
— |
| RS2080316641 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080317430 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080318979 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080330778 |
SPTBN4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2080338119 |
MED13
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder 61, Intellectual developmental disorder 61 |
| RS2080364920 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS2080404297 |
SPTBN4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2080414407 |
TTN
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS2080417973 |
GMPPB
|
Health Risk |
Likely pathogenic |
— |
| RS2080421905 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2080423660 |
GMPPB
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2080426663 |
GMPPB
|
Health Risk |
Pathogenic/Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2080427976 |
GMPPB
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2T, Autosomal recessive limb-girdle muscular dystrophy type 2T |
| RS2080439314 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080439797 |
EFNB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080456894 |
GMPPB
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS2080468475 |
EFNB1
|
Health Risk |
Pathogenic |
— |
| RS2080468583 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080468871 |
EFNB1
|
Health Risk |
Pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080471329 |
EFNB1
|
Health Risk |
Likely pathogenic |
— |
| RS2080471528 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080472731 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2080473382 |
EFNB1
|
Health Risk |
Likely pathogenic |
Craniofrontonasal syndrome, Craniofrontonasal syndrome |
| RS2080473458 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Gastric cancer |
| RS2080475075 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2080479088 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080482247 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080483369 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2080505282 |
SPTBN4
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with hypotonia, neuropathy |
| RS2080510348 |
DMD
|
Health Risk |
Pathogenic |
Becker muscular dystrophy, Becker muscular dystrophy |
| RS2080511514 |
IGSF1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, X-linked central congenital hypothyroidism with late-onset testicular enlargement |
| RS2080514041 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2080555011 |
SPTBN4
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2080573967 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080577927 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2080584788 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2080623161 |
NEB
|
Health Risk |
Pathogenic/Likely pathogenic |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS2080629778 |
ZBTB20
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2080654412 |
ARID1A
|
Health Risk |
Pathogenic |
Malignant tumor of urinary bladder, Malignant tumor of urinary bladder |
| RS2080669968 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2080670725 |
STK11
|
Health Risk |
Likely pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2080670808 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2080673271 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2080673579 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS2080673604 |
STK11
|
Health Risk |
Pathogenic |
Peutz-Jeghers syndrome, Peutz-Jeghers syndrome |
| RS2080677629 |
TMEM231
|
Health Risk |
Pathogenic |
Joubert syndrome and related disorders, Joubert syndrome and related disorders |
| RS2080685279 |
TMEM231
|
Health Risk |
Pathogenic |
Meckel syndrome, type 11 |
| RS2080691297 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2080691379 |
ZBTB20
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |